Source: Eur Respir J 2008; 31: 1183-1188
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Han M. K., Murray S., Fell C. D., Flaherty K. R., Toews G. B., Myers J., Colby T. V., Travis W. D., Kazerooni E. A., Gross B. H., Martinez F. J.. Sex differences in physiological progression of idiopathic pulmonary fibrosis. Eur Respir J 2008; 31: 1183-1188

Member's Comments

No comment yet.

Related content which might interest you: The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 96-103 Year: 2005 Correlation of composite physiologic index with 6-minute walk test variables in patients with idiopathic interstitial pneumonias Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016 A six minute walking test (6MWT) derived index (O2-GAP) predicts mortality in IPF Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 What is the role of hypoxaemia, 6-minute walk test, diffusion capacity, pulmonary arterial hypertension in diffuse interstitial lung diseases? Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Challenges in idiopathic pulmonary fibrosis trials: the point on end-points Source: Eur Respir Rev 2011; 20: 195-200 Year: 2011 The relation of six-minute walk test and lung function in interstitial lung disease Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Effect of continued pirfenidone treatment following a ≥ 15% decline in 6-minute walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from 3 pivotal studies Source: International Congress 2016 – New and old therapies for chronic lung diseases Year: 2016 Change in 6-minute walk test can predict prognosis in idiopathic pulmonary fibrosis Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Variables associated to desaturation during the six-minute walking test in interstitial lung disease Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change Source: Eur Respir J, 55 (5) 1902151; 10.1183/13993003.02151-2019 Year: 2020 The six minute walking test: Clinical predictors of survival in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013 Clinical significance of falling oxygen saturation per walking distance (ΔSaO2/6MWD) during six minute walk test (6MWT) in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Idiopathic pulmonary fibrosis: Gender differences in survival and functional decline. A retrospective study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema Source: Eur Respir J 2011; 37: 176-183 Year: 2011 Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 564-569 Year: 2002 Clinical predictors of pulmonary hypertension in sarcoidosis Source: Eur Respir J 2008; 32: 296-302 Year: 2008 A progression-free end-point for idiopathic pulmonary fibrosis trials: lessons from cancer Source: Eur Respir J 2013; 41: 262-269 Year: 2013 The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Source: Eur Respir J 2004; 23: 28-33 Year: 2004 Cardiorespiratory responses during the 6-minute walk and stepper tests in patients with interstitial lung disease Source: International Congress 2015 – Pathophysiological mechanisms at different scales: lung, airways, muscles and symptom perception Year: 2015